Bharat Biotech's COVID-19 vaccine Covaxin recommended by expert panel for phase II/III clinical trials on 2 to 18 year-olds: Sources PTI PLB AAR AAR

PTI | New Delhi | Updated: 12-05-2021 00:16 IST | Created: 12-05-2021 00:16 IST

Bharat Biotech's COVID-19 vaccine Covaxin recommended by expert panel for phase II/III clinical trials on 2 to 18 year-olds: Sources PTI PLB AAR AAR

Country:
India

Bharat Biotech's COVID-19 vaccine Covaxin recommended by expert panel for phase II/III clinical trials on 2 to 18 year-olds: Sources PTI PLB AAR AAR

TRENDING

1

Full Construction Starts on New Pepe Stream Bridge

Full Construction Starts on New Pepe Stream Bridge

New Zealand

2

New Zealand Backs West Coast Critical Minerals Processing

New Zealand Backs West Coast Critical Minerals Processing

New Zealand

3

Bilateral Boost: Modi and Prabowo Forge Stronger Indo-Indonesian Ties

Bilateral Boost: Modi and Prabowo Forge Stronger Indo-Indonesian Ties

Global

4

Devastation in Venezuela: Earthquake's Impact and Response

Devastation in Venezuela: Earthquake's Impact and Response

Global

PERSPECTIVES AND INSIGHTS

Can Better Finance and Infrastructure Unlock West Africa's $480 Billion Food Market by 2030?

Why Some Low-Income Nations Become Frontier Markets While Others Miss the Investment Opportunity

UNDP Calls for Stronger AI Governance as Public Services Face Rising Trust and Safety Challenges

The Water-Energy Trap: Why Today’s Sustainability Fixes Could Create Tomorrow’s Crisis

DevShots

Latest News

Connect us on

Facebook Twitter LinkedIn Quora Youtube

Google News RSS

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

Name

Email

Message

By submitting, you agree that we may use your email address to respond.

Web Analytics Made Easy - Statcounter